Vaccines are the most feasible and cost-effective strategy for protecting, controlling and reducing infectious disease in
both animal species and humans. Despite, the significant use of vaccines, formulation of effective and safe vaccine
is needed to afford sufficient protection through usage of appropriate adjuvants. Adjuvants are chemicals, proteins
or derivatives of microbial formulated with vaccines to enhance innate and adaptive immune response to vaccine
antigens by a variety of mechanisms. The term adjuvant comes from Latin word “adjuvare” which means to help and
discovered in early 1920s. Many molecules have been considered as an adjuvant including aluminium salts (alum),
oil emulsions, saponins, ISCOMs, liposomes, VLPs, cytokines, combined adjuvants and derivatives of bacteria are
among in use and explored vaccine adjuvants. Mainly they have been classified according to their mechanism of action
as: delivery system and immunostimulatory adjuvants. The mode of action of these compounds is different. Their
action is not yet fully understood due to the complexity of the immune response, but general mechanism has been
explained. Recent advances of vaccine adjuvants reveal their ability to activate innate immune system by targeting
receptors (PRR) expressed on immune cells. Therefore, discovering new adjuvant that are essential components of
vaccine formulations helps the development of more potent vaccine, which induce strong immune response. Better
understanding of new adjuvant also improves the future design of effective vaccine against infectious pathogens.
This review, provide an overview on current knowledge about the effect of adjuvants, general mechanisms and
characteristics of recent vaccine adjuvants.